首页> 美国卫生研究院文献>Oncotarget >Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression
【2h】

Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression

机译:慢病毒介导的胰岛素样生长因子-1受体的RNAi抑制通过下调中间因子表达抑制肝细胞癌的生长和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The insulin-like growth factor-1 receptor (IGF-1R) overexpression contributes to the development of a variety of cancers. The present study explored the role of IGF-1R in the development and progression of hepatocellular carcinoma (HCC) and the possibility of IGF-1R silencing by lentivirus-mediated RNA interference (RNAi) as a therapeutic target for HCC. We showed that IGF-1R mRNA was up-regulated in Huh7 and Hep3B cells and human HCC tissues, and that IGF-1R knockdown by RNAi led to decreased proliferation, apoptosis induction, and decreased migration and invasion of Huh7 and Hep3B cells. Further, the in vivo study indicated that IGF-1R knockdown markedly diminished the tumorigenesis and metastasis of Huh7 xenograft. Moreover, the intratumoral administration of lentivirus-IGF-1R siRNA led to significant tumor growth inhibition in an established Huh7 xenograft model. Mechanistic investigations showed that midkine was found to be the most significantly down-regulated protein in Huh7 cells with IGF-1R knockdown, and ectopic overexpression of midkine significantly rescued inhibition of Huh7 cell proliferation, migration, and invasion caused by IGF-1R suppression. Collectively, these data suggest that IGF-1R inhibition by RNAi can significantly suppress HCC growth and invasion at least partially through down-regulating midkine expression, and IGF-1R is a potential target for HCC gene therapy.
机译:胰岛素样生长因子-1受体(IGF-1R)的过表达有助于多种癌症的发展。本研究探讨了IGF-1R在肝细胞癌(HCC)的发展和进程中的作用,以及通过慢病毒介导的RNA干扰(RNAi)使IGF-1R沉默作为HCC的治疗靶标的可能性。我们显示,IGF-1R mRNA在Huh7和Hep3B细胞以及人类HCC组织中上调,而RNAi抑制IGF-1R导致增殖,凋亡诱导以及Huh7和Hep3B细胞的迁移和侵袭减少。此外,体内研究表明,IGF-1R敲低显着减少了Huh7异种移植物的肿瘤发生和转移。此外,在已建立的Huh7异种移植模型中,慢病毒-IGF-1R siRNA的肿瘤内给药导致明显的肿瘤生长抑制。机理研究表明,在具有IGF-1R抑制作用的Huh7细胞中,midkine被发现是最显着下调的蛋白,而异位表达Midkine则可以通过抑制IGF-1R抑制Huh7细胞的增殖,迁移和侵袭。总体而言,这些数据表明,RNAi对IGF-1R的抑制作用可以至少部分地通过下调中间因子表达来显着抑制HCC的生长和侵袭,而IGF-1R是HCC基因治疗的潜在靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号